Qube Research & Technologies (QRT)
PRCT icon

Qube Research & Technologies (QRT)’s Procept Biorobotics PRCT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-42,100
Closed -$2.42M – 3866
2025
Q2 		$2.42M Sell
42,100
-190,894
-82% -$10.8M ﹤0.01% 2120
2025
Q1 		$13.6M Buy
232,994
+73,289
+46% +$5M 0.02% 949
2024
Q4 		$12.9M Buy
159,705
+131,513
+466% +$11.2M 0.02% 950
2024
Q3 		$2.26M Sell
28,192
-7,859
-22% -$558K ﹤0.01% 1718
2024
Q2 		$2.2M Buy
+36,051
New +$2.14M ﹤0.01% 1574
2023
Q2 		– Sell
-15,027
Closed -$427K – 2869
2023
Q1 		$427K Buy
+15,027
New +$530K ﹤0.01% 1612
2022
Q4 		– Sell
-9,005
Closed -$373K – 2884
2022
Q3 		$373K Sell
9,005
-113,013
-93% -$4.51M ﹤0.01% 1560
2022
Q2 		$3.99M Buy
+122,018
New +$4.44M 0.03% 569
2021
Q4 		– Sell
-9,108
Closed -$347K – 2877
2021
Q3 		$347K Buy
+9,108
New +$350K ﹤0.01% 1419

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PRCT Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 42,100 shares — an estimated $2.42M sold.

Qube Research & Technologies (QRT) first reported a position in PRCT in Q3 2021 and held it in 9 quarters. The position peaked at $13.6M in Q1 2025. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 42,100 Procept Biorobotics shares in Q3 2025, an estimated $2.42M.
  • Qube Research & Technologies (QRT) first reported a position in Procept Biorobotics in Q3 2021 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Procept Biorobotics position peaked at $13.6M in Q1 2025.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.